Capricor Therapeutics, Inc. (CAPR)
6.88
-0.59
(-7.90%)
USD |
NASDAQ |
Oct 13, 16:00
6.93
+0.05
(+0.73%)
After-Hours: 06:38
Capricor Therapeutics Total Return Price : 6.88 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 6.88 |
| October 12, 2026 | 7.47 |
| October 09, 2026 | 7.83 |
| October 08, 2026 | 8.01 |
| October 07, 2026 | 8.10 |
| October 06, 2026 | 7.75 |
| October 05, 2026 | 7.78 |
| October 02, 2026 | 8.95 |
| October 01, 2026 | 8.94 |
| September 30, 2026 | 9.47 |
| September 29, 2026 | 8.57 |
| September 28, 2026 | 8.71 |
| September 25, 2026 | 8.36 |
| September 24, 2026 | 8.57 |
| September 23, 2026 | 8.67 |
| September 22, 2026 | 9.34 |
| September 21, 2026 | 8.90 |
| September 18, 2026 | 9.06 |
| September 17, 2026 | 9.42 |
| September 16, 2026 | 8.56 |
| September 15, 2026 | 8.56 |
| September 14, 2026 | 8.81 |
| September 11, 2026 | 8.37 |
| September 10, 2026 | 8.30 |
| September 09, 2026 | 8.64 |
| Date | Value |
|---|---|
| September 08, 2026 | 9.06 |
| September 04, 2026 | 9.40 |
| September 03, 2026 | 9.28 |
| September 02, 2026 | 9.89 |
| September 01, 2026 | 10.01 |
| August 31, 2026 | 9.91 |
| August 28, 2026 | 9.59 |
| August 27, 2026 | 10.06 |
| August 26, 2026 | 9.36 |
| August 25, 2026 | 8.29 |
| August 24, 2026 | 6.80 |
| August 21, 2026 | 6.29 |
| August 20, 2026 | 6.835 |
| August 19, 2026 | 7.98 |
| August 18, 2026 | 7.08 |
| August 17, 2026 | 7.45 |
| August 14, 2026 | 6.65 |
| August 13, 2026 | 4.21 |
| August 12, 2026 | 4.19 |
| August 11, 2026 | 3.93 |
| August 10, 2026 | 3.85 |
| August 07, 2026 | 4.09 |
| August 06, 2026 | 4.18 |
| August 05, 2026 | 3.93 |
| August 04, 2026 | 4.17 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| ARS Pharmaceuticals, Inc. | 4.05 |
| SELLAS Life Sciences Group, Inc. | 12.41 |
| Sionna Therapeutics, Inc. | 4.38 |
| Alnylam Pharmaceuticals, Inc. | 223.82 |
| Cytokinetics, Inc. | 61.62 |